Sort   by:  
 Page size 
UnknownPre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
Not available
S-EPMC8732273 | biostudies-literature
UnknownImmune boosting by B.1.1.529 <b>(</b>Omicron) depends on previous SARS-CoV-2 exposure.
Not available
S-EPMC9210451 | biostudies-literature
UnknownHLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19.
Not available
S-EPMC9111350 | biostudies-literature
UnknownHealthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19.
Not available
S-EPMC7836029 | biostudies-literature
UnknownQuantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response.
Not available
S-EPMC9372021 | biostudies-literature
UnknownBlood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.
Not available
S-EPMC8260104 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownHigher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607 | biostudies-literature
UnknownConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538 | biostudies-literature
Sort   by:  
 Page size